Skip to main content
. 2021 Oct 14;11:20485. doi: 10.1038/s41598-021-99894-6

Table 3.

Logistic analysis for RA patients with severe sarcopenia.

Variables Univariate Multivariate
Model 1 Model 2 Model 3
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Age (1 year) 1.15 (1.08–1.22)  < 0.0001 1.17 (1.09–1.25)  < 0.0001 1.21 (1.10–1.33)  < 0.0001 1.21 (1.10–1.33)  < 0.0001
Body mass index (1 kg/m2) 0.76 (0.67–0.86)  < 0.0001 0.72 (0.62–0.84)  < 0.0001 0.76 (0.60–0.95) 0.0085 0.76 (0.60–0.95) 0.010
Low 25(OH)D status (≦16.0 ng/ml) 4.25 (1.99–9.09)  < 0.0001 4.42 (1.80–10.8) 0.0007 5.92 (1.98–17.7) 0.0006 6.00 (1.99–18.08) 0.0006
DAS28-ESR 1.58 (1.09–2.31) 0.015 1.03 (0.62–1.74) 0.90 1.23 (0.86–1.76) 0.88
Stage (3, 4 vs. 1, 2) 4.44 (1.74–11.4) 0.0005 4.33 (1.33–14.08) 0.0010 4.40 (1.35–14.32) 0.0097
HAQ 4.03 (2.19–7.41)  < 0.0001
Methotrexate use 0.58 (0.28–1.19) 0.14 2.18 (0.66–7.22) 0.19 2.18 (0.66–7.22) 0.19
Prednisolone use 2.91 (1.39–6.11) 0.0049 2.45 (0.74–8.06) 0.09 2.45 (0.74–8.06) 0.13
Biological agents use 0.47 (0.21–1.03) 0.058 0.70 (0.22–2.21) 0.52 0.70 (0.22–2.21) 0.54
MNA-SF 0.70 (0.59–0.85)  < 0.0001 0.91 (0.66–1.24) 0.54 0.90 (0.66–1.24) 0.53
Osteoporosis medication (+) 1.72 (0.82–3.59) 0.15 1.22 (0.40–3.72) 0.73

Results of univariate (left) and multivariate (right) logistic analyses for independent variables associated with severe sarcopenia. Model 1 was adjusted for vitamin D status, age, and body mass index. Model 2 was adjusted for variables in model 1 plus nutrition status (MNA-SF), and RA-related factors (DAS28-ESR, Stage, HAQ, and therapeutics (use of prednisolone, biologics, and methotrexate)). Model 3 was adjusted for variables in model 2 plus the prevalence of osteoporosis medication.

RA rheumatoid arthritis, DAS28 disease activity score using 28 joints, HAQ health assessment questionnaire, MNA-SF Mini Nutritional Assessment Short-Form.